1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61D4FC968AA736D3785257A610072A680
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/1D4FC968AA736D3785257A610072A680!OpenDocument
18
19OpenDocument
2044.220.247.152
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Sales and Marketing » New Product Development and Launch » Ensuring Market Focus » Customer and Thought Leader Involvement

Document Excerpt: Cymbalta Case Study: Using Market-Entry Delays to Develop Customer Insights that Help Grow a Blockbuster

DB Image

ID: MD-334


Features:

29 Info Graphics

3 Data Graphics

40 Metrics

9 Narratives


Pages/Slides: 4


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".

To return to the study abstract to purchase the full study
- click here.

This excerpt includes research findings and metrics from document #5221 "Cymbalta Case Study: Using Market-Entry Delays to Develop Customer Insights that Help Grow a Blockbuster."

Industries Profiled:
Pharmaceutical


Companies Profiled:
Eli Lilly

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.